drugset / Trial / NCT01250210
Evaluation of Pharmacodynamic Effects on Ovulation and Cycle Control
RandomizedParallel-groupOpen-labelTreatment
Summary
Evaluate the adequacy of ovulation suppression, cycle control, and safety of three transdermal contraceptive delivery systems (TCDSs).
Timeline
- Start
- 2007-09
- Primary completion
- 2008-02
- Completion
- 2008-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levonorgestrel | Small molecule | 2.17 mg | — |
| Subject | Levonorgestrel | Small molecule | 2.6 mg | — |
| Subject | ethinyl estradiol | Small molecule | 1.28 mg | — |
| Subject | ethinyl estradiol | Small molecule | 1.92 mg | — |
| Subject | ethinyl estradiol | Small molecule | 2.3 mg | — |